Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vernalis (Apokyn & Vernalis US Commercial Operations)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pharmaceutical products. The company is engaged in the research and development of pharmaceutical products to cure oncology, endocrinology, neuron and therapeutic diseases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • Oakdene Court, 613 Reading Road
  • Winnersh
  • Wokingham RG41 5UA
  • England

Vernalis (Apokyn & Vernalis US Commercial Operations) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vernalis (Apokyn & Vernalis US Commercial Operations)‘s full profile, request access.

Request full access to PitchBook

Vernalis (Apokyn & Vernalis US Commercial Operations) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Vernalis (Apokyn & Vernalis US Commercial Operations)‘s full profile, request access.

Request full access to PitchBook